Olink Holding AB provides accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients.
Company profile
Ticker
OLK
Exchange
Website
CEO
Jon Heimer
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Knilo HoldCo AB
SEC CIK
OLK stock data
Latest filings (excl ownership)
6-K
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
19 Apr 24
20-F
2023 FY
Annual report (foreign)
25 Mar 24
6-K
Olink reports fourth quarter and full year 2023 financial results
25 Mar 24
6-K
Current report (foreign)
15 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
6 Mar 24
6-K
Current report (foreign)
6 Mar 24
SC 14D9/A
Tender offer solicitation (amended)
1 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
1 Mar 24
SC 14D9/A
Tender offer solicitation (amended)
20 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
20 Feb 24
Latest ownership filings
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 24
SC 13G
FIL Ltd
9 Feb 24
SC 13G/A
FMR LLC
13 Nov 23
144
Notice of proposed sale of securities
17 Aug 23
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 23
SC 13G/A
Futur Pension Forsakringsaktiebolag
14 Feb 23
SC 13G/A
FMR LLC
10 Feb 23
SC 13G/A
FMR LLC
9 Feb 23
SC 13G/A
FMR LLC
12 Dec 22
SC 13G
Summa Equity AB
14 Feb 22
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Institutional ownership, Q2 2023
42.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 56 |
Opened positions | 7 |
Closed positions | 6 |
Increased positions | 20 |
Reduced positions | 14 |
13F shares | Current |
---|---|
Total value | 504.74 bn |
Total shares | 52.22 mm |
Total puts | 87.60 k |
Total calls | 1.90 k |
Total put/call ratio | 46.1 |
Largest owners | Shares | Value |
---|---|---|
FMR | 12.41 mm | $232.70 bn |
Summa Equity AB | 12.17 mm | $0.00 |
T. Rowe Price | 10.05 mm | $188.51 mm |
T. Rowe Price Investment Management | 1.95 mm | $36.62 mm |
Capital International Investors | 1.86 mm | $34.91 bn |
Rock Springs Capital Management | 1.65 mm | $31.01 bn |
Jennison Associates | 1.59 mm | $29.85 bn |
Clearbridge Advisors | 1.50 mm | $28.10 bn |
Woodline Partners | 1.11 mm | $20.81 bn |
Lord, Abbett & Co. | 1.03 mm | $19.27 mm |
News
Morgan Stanley Maintains Equal-Weight on Olink Holding, Maintains $26 Price Target
26 Mar 24
Canaccord Genuity Reiterates Hold on Olink Holding, Maintains $26 Price Target
26 Mar 24
Recap: Olink Holding Q4 Earnings
25 Mar 24
Olink Holding Q4 EPS $(0.06) Misses $0.15 Estimate, Sales $68.55M Miss $89.86M Estimate
25 Mar 24
Press releases
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
19 Apr 24
Olink publishes 2023 annual report
25 Mar 24
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
15 Mar 24
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results
31 Jan 24